Cytosorbents Corporation CTSO
4.60 USD +0.04 (+0.88%)
At closeNov 5, 2026, 4:00 PM EST
4.62 +0.02 +0.43%
After hours · Nov 5, 4:00 PM ET
4.11 Day range 4.68
2.84 52-week range 17.00
- YTD
- -64.01%
- 1 year
- -69.13%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 37.06M | 35.59M | 31.08M | 34.69M | 43.17M | |
| 26.49M | 24.89M | 21.95M | 20.73M | 32.12M | |
| -14.75M | -16.45M | -31.95M | -31.52M | -22.74M | |
| -8.20M | -20.72M | -29.25M | -32.81M | -24.56M | |
| -2.60 | -7.60 | -13.00 | -15.00 | -11.40 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 7.77M | 9.76M | 15.62M | 23.83M | 53.83M | |
| 44.18M | 47.37M | 52.96M | 63.23M | 89.52M | |
| 38.28M | 36.27M | 29.48M | 27.86M | 26.94M | |
| 28.57M | 26.44M | 17.94M | 18.14M | 13.25M | |
| 5.90M | 11.11M | 23.48M | 35.37M | 62.58M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -12.38M | -14.43M | -21.66M | -28.23M | -14.01M | |
| -415.00K | -669.00K | -936.24K | -6.46M | -4.28M | |
| 9.31M | 9.33M | 14.47M | 4.96M | 715.20K | |
| -88.00K | -284.00K | -538.12K | -6.09M | -3.64M | |
| -1.99M | -5.85M | -8.22M | -29.99M | -17.60M |